Users Online: 462
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
NEURO ONCOLOGY: REVIEW ARTICLE
Year : 2015  |  Volume : 4  |  Issue : 4  |  Page : 163-173

Recurrent Glioblastoma: Where we stand


Department of Radiotherapy, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India

Date of Web Publication8-Feb-2016

Correspondence Address:
Sanjoy Roy
Department of Radiotherapy, Chittaranjan National Cancer Institute, Kolkata, West Bengal
India
Login to access the Email id

Source of Support: Phase II and III rct/non rct study; PubMed; 2004-2011., Conflict of Interest: None


DOI: 10.4103/2278-330X.175953

Rights and Permissions

How to cite this article:
Roy S, Lahiri D, Maji T, Biswas J. Recurrent Glioblastoma: Where we stand. South Asian J Cancer 2015;4:163-73

How to cite this URL:
Roy S, Lahiri D, Maji T, Biswas J. Recurrent Glioblastoma: Where we stand. South Asian J Cancer [serial online] 2015 [cited 2018 Nov 20];4:163-73. Available from: http://journal.sajc.org/text.asp?2015/4/4/163/175953

This article has been retracted for infringement of copyright and code of ethics.





This article has been cited by
1 Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion
Bárbara da Silva,Ryan K. Mathew,Euan S. Polson,Jennifer Williams,Heiko Wurdak
SLAS DISCOVERY: Advancing Life Sciences R&D. 2018; 23(8): 862
[Pubmed] | [DOI]
2 Towards an advanced cell-based in vitro glioma model system
Valeriia Mikhailova,Valeriia Gulaia,Vladlena Tiasto,Stanislav Rybtsov,Margarita Yatsunskaya,Alexander Kagansky
AIMS Genetics. 2018; 5(2): 91
[Pubmed] | [DOI]
3 Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
Bryan G. Harder,Mylan R. Blomquist,Junwen Wang,Anthony J. Kim,Graeme F. Woodworth,Jeffrey A. Winkles,Joseph C. Loftus,Nhan L. Tran
Frontiers in Oncology. 2018; 8
[Pubmed] | [DOI]
4 Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
Kshama Gupta,Terry C. Burns
Frontiers in Oncology. 2018; 8
[Pubmed] | [DOI]
5 Approved Treatments for Patients with Recurrent High-grade Gliomas
Caroline Kane Laub,Jennifer Stefanik,Lisa Doherty
Seminars in Oncology Nursing. 2018;
[Pubmed] | [DOI]
6 Localized targeted antiangiogenic drug delivery for glioblastoma
Gregory D. Arnone,Abhiraj D. Bhimani,Tania Aguilar,Ankit I. Mehta
Journal of Neuro-Oncology. 2018;
[Pubmed] | [DOI]
7 Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient in vivo fluorescence image-guided photothermal therapy
Xiaolei Cai,Aishwarya Bandla,Chan Kim Chuan,Gayathiri Magarajah,Lun-De Liao,Daniel Boon Loong Teh,Brian K. Kennedy,Nitish V. Thakor,Bin Liu
Materials Horizons. 2018;
[Pubmed] | [DOI]
8 Bright Future for Novel Viral Glioblastoma Multiforme Therapy
David McCarthy,Dallas Sheinberg,Ricardo J. Komotar,Robert M. Starke
World Neurosurgery. 2018;
[Pubmed] | [DOI]
9 Molecular biology as a tool for the treatment of cancer
Carla de Castro Sant’ Anna,Alberto Gomes Ferreira Junior,Paulo Soares,Fabricio Tuji,Eric Paschoal,Luiz Cláudio Chaves,Rommel Rodriguez Burbano
Clinical and Experimental Medicine. 2018;
[Pubmed] | [DOI]
10 Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection
C. Bastiancich,J. Bianco,K. Vanvarenberg,B. Ucakar,N. Joudiou,B. Gallez,G. Bastiat,F. Lagarce,V. Préat,F. Danhier
Journal of Controlled Release. 2017;
[Pubmed] | [DOI]
11 A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy
Lei Yin,Heng Li,Wenjian Liu,Zhenglin Yao,Zhenzhen Cheng,Huabei Zhang,Hui Zou
European Journal of Medicinal Chemistry. 2017;
[Pubmed] | [DOI]
12 Validation of an established prognostic score after re-irradiation of recurrent glioma
Kerstin A. Kessel,Josefine Hesse,Christoph Straube,Claus Zimmer,Friederike Schmidt-Graf,Jürgen Schlegel,Bernhard Meyer,Stephanie E. Combs
Acta Oncologica. 2017; : 1
[Pubmed] | [DOI]
13 Randomized Trial for Short-Term Radiation Therapy With Temozolomide in Elderly Patients With Glioblastoma
David J. McCarthy,Ricardo J. Komotar,Robert M. Starke,E. Sander Connolly
Neurosurgery. 2017; 81(3): N21
[Pubmed] | [DOI]
14 Advances in Brain Tumor Surgery for Glioblastoma in Adults
Montserrat Lara-Velazquez,Rawan Al-Kharboosh,Stephanie Jeanneret,Carla Vazquez-Ramos,Deependra Mahato,Daryoush Tavanaiepour,Gazanfar Rahmathulla,Alfredo Quinones-Hinojosa
Brain Sciences. 2017; 7(12): 166
[Pubmed] | [DOI]
15 Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
Benxu Cheng,Liza Doreen Morales,Yonghong Zhang,Shizue Mito,Andrew Tsin,Salvatore V Pizzo
PLOS ONE. 2017; 12(9): e0184324
[Pubmed] | [DOI]
16 Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug
Sheng Zhong,Bo Wu,Xuechao Dong,Yujuan Han,Shanshan Jiang,Ying Zhang,Yang Bai,Sean X. Luo,Yong Chen,Huimao Zhang,Gang Zhao
World Neurosurgery. 2017;
[Pubmed] | [DOI]
17 Recurrent glioblastoma: a single-institution experience with reirradiation and temozolomide
Tejinder Kataria,Deepak Gupta,Ratika Gupta,Shikha Goyal,Shyam Singh Bisht,Trinanjan Basu,Ashu Abhishek,Kushal Narang,Susovan Banerjee
Journal of Radiation Oncology. 2017;
[Pubmed] | [DOI]
18 Harnessing nanomedicine for therapeutic intervention in glioblastoma
Anna Gutkin,Zvi R. Cohen,Dan Peer
Expert Opinion on Drug Delivery. 2016; : 1
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article

 Article Access Statistics
    Viewed2690    
    Printed26    
    Emailed1    
    PDF Downloaded659    
    Comments [Add]    
    Cited by others 18    

Recommend this journal